IP Library Granted Patent US 1,097,166
Granted Patent S1
US 1,097,166 · App. 29/796,477 · Granted Oct 7, 2025

Dermatology adhesive patch

Inventor: John Dobak, III (La Jolla, CA)
Assignee: DERMTECH, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 1,097,166
App. No.
29/796,477
Granted
Oct 7, 2025
Kind
S1
Claims (1)

The ornamental design for a dermatology adhesive patch, as shown and described.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2025
From: DOBAK, JOHN
To: DERMTECH, INC.
Reel/Frame 069823/0634 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2024
From: DERMTECH, INC.; DERMTECH OPERATIONS, INC.
To: DERM – JES HOLDINGS, LLC
Reel/Frame 069231/0065 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2024
From: DERM – JES HOLDINGS LLC
To: DERMTECH, LLC
Reel/Frame 069231/0216 →
Continuity (4)
Continuation 17183589 · Feb 24, 2021
Continuation 17002676 · Aug 25, 2020
Continuation 16886611 · May 28, 2020
Continuation 15571247
References Cited (390)
US 3731683A · Zaffaroni · 1973 [cited by examiner]
US 4122947A · Falla · 1978 [cited by applicant]
US 5160315A · Heinecke · 1992 [cited by examiner]
US 5190049A · Briggs et al. · 1993 [cited by applicant]
US D355489S · Almond · 1995 [cited by examiner]
US 5438984A · Schoendorfer · 1995 [cited by examiner]
US 5921396A · Brown, Jr. · 1999 [cited by applicant]
US 5989815A · Skolnick et al. · 1999 [cited by applicant]
US 5994149A · Robinson et al. · 1999 [cited by applicant]
US 6106732A · Johnston et al. · 2000 [cited by applicant]
US 6176836B1 · Trudil et al. · 2001 [cited by applicant]
US 6203987B1 · Friend et al. · 2001 [cited by applicant]
US 6300140B1 · Robinson et al. · 2001 [cited by applicant]
US 6355439B1 · Chung et al. · 2002 [cited by applicant]
US 6447463B1 · Borkowski · 2002 [cited by applicant]
US D480811S · Horhota · 2003 [cited by examiner]
US D481131S · Saim · 2003 [cited by examiner]
US 6720145B2 · Rheins et al. · 2004 [cited by applicant]
US 6949338B2 · Rheins et al. · 2005 [cited by applicant]
US D512509S · Yamasoto · 2005 [cited by examiner]
US D513639S · Saim · 2006 [cited by examiner]
US D516727S · Neri · 2006 [cited by examiner]
US 7129389B1 · Watson · 2006 [cited by examiner]
US 7183057B2 · Benson · 2007 [cited by applicant]
US 7247426B2 · Yakhini et al. · 2007 [cited by applicant]
US 7267951B2 · Alani et al. · 2007 [cited by applicant]
US 7297480B2 · Vogt · 2007 [cited by applicant]
US D576282S · Yanaki · 2008 [cited by examiner]
US 7662558B2 · Liew · 2010 [cited by applicant]
US D618357S · Navies · 2010 [cited by examiner]
US D620123S · Igwebuike · 2010 [cited by examiner]
US 7771950B2 · Wohlgemuth et al. · 2010 [cited by applicant]
US 7919246B2 · Lai et al. · 2011 [cited by applicant]
US 7921999B1 · Kimball · 2011 [cited by applicant]
US 7972788B2 · Miyata et al. · 2011 [cited by applicant]
US 7989165B2 · Benson · 2011 [cited by applicant]
US 8067173B2 · Liew · 2011 [cited by applicant]
US D673166S · Mori et al. · 2012 [cited by applicant]
US 8492102B2 · Kashani-Sabet et al. · 2013 [cited by applicant]
US D688377S · Heinecke · 2013 [cited by examiner]
US 8541170B2 · Kennedy et al. · 2013 [cited by applicant]
US D692149S · Uematsu · 2013 [cited by applicant]
US D692152S · Inoo · 2013 [cited by applicant]
US D704343S · Inoo et al. · 2014 [cited by applicant]
US 8938684B2 · Guertler et al. · 2015 [cited by applicant]
US 9057109B2 · Chang · 2015 [cited by applicant]
US D738514S · Tagami et al. · 2015 [cited by applicant]
US D745973S · Russo · 2015 [cited by examiner]
US D747455S · Uematsu · 2016 [cited by applicant]
US D759828S · Riedle · 2016 [cited by examiner]
US D764580S · Solomon et al. · 2016 [cited by applicant]
US D764581S · Solomon et al. · 2016 [cited by applicant]
US D773060S · Narvekar · 2016 [cited by examiner]
US D785189S · Dettmar · 2017 [cited by examiner]
US D786282S · Donnelly · 2017 [cited by applicant]
US D787689S · Roberts · 2017 [cited by examiner]
US D788142S · Burke · 2017 [cited by applicant]
US D808026S · Moore · 2018 [cited by examiner]
US D816697S · Ledford et al. · 2018 [cited by applicant]
US D816699S · Ledford et al. · 2018 [cited by applicant]
US D816700S · Bayer et al. · 2018 [cited by applicant]
US D857212S · Sugaya et al. · 2019 [cited by applicant]
US 10407729B2 · Chang · 2019 [cited by applicant]
US D865056S · Martin · 2019 [cited by applicant]
US 10631983B1 · Christianson · 2020 [cited by examiner]
US 10709428B2 · Palmer et al. · 2020 [cited by applicant]
US 10781200B2 · Mcdonald et al. · 2020 [cited by applicant]
US D899606S · Kang · 2020 [cited by applicant]
US D899607S · Ryu · 2020 [cited by applicant]
US D929596S · Yu · 2021 [cited by examiner]
US D944284S · Metzger et al. · 2022 [cited by applicant]
US D944286S · Sanchez et al. · 2022 [cited by applicant]
US D946017S · Courtney et al. · 2022 [cited by applicant]
US 11307876B1 · Leonard, II et al. · 2022 [cited by applicant]
US D954273S · Wallace · 2022 [cited by examiner]
US D966299S · Dobak, III et al. · 2022 [cited by applicant]
US D966300S · Dobak, III et al. · 2022 [cited by applicant]
US 11578373B2 · Dobak, III et al. · 2023 [cited by applicant]
US 11643689B2 · Dobak, III et al. · 2023 [cited by applicant]
US D988399S · Dobak, III et al. · 2023 [cited by applicant]
US D989861S · Dobak, III et al. · 2023 [cited by applicant]
US D1012296S · Ehouarn · 2024 [cited by examiner]
US D1012297S · Ehouarn · 2024 [cited by examiner]
US D1023321S · Kenney · 2024 [cited by examiner]
US D1048417S · Wassink · 2024 [cited by examiner]
US 20010024783A1 · Iversen · 2001 [cited by applicant]
US 20020110824A1 · Rheins et al. · 2002 [cited by applicant]
US 20020115086A1 · Rheins et al. · 2002 [cited by applicant]
US 20020119471A1 · Rheins et al. · 2002 [cited by applicant]
US 20020127573A1 · Rheins et al. · 2002 [cited by applicant]
US 20020150918A1 · Rheins et al. · 2002 [cited by applicant]
US 20030045810A1 · Borkowski · 2003 [cited by applicant]
US 20030098580A1 · Christy · 2003 [cited by applicant]
US 20030108896A1 · Vogt · 2003 [cited by applicant]
US 20030113906A1 · Sangha et al. · 2003 [cited by applicant]
US 20030152923A1 · Yakhini et al. · 2003 [cited by applicant]
US 20030171328A1 · Iversen · 2003 [cited by applicant]
US 20030175736A1 · Chinnaiyan et al. · 2003 [cited by applicant]
US 20030228617A1 · Aune et al. · 2003 [cited by applicant]
US 20050221334A1 · Benson · 2005 [cited by applicant]
US 20060019256A1 · Clarke et al. · 2006 [cited by applicant]
US 20060040335A1 · Butt et al. · 2006 [cited by applicant]
US 20060153816A1 · Brown et al. · 2006 [cited by applicant]
US 20060242554A1 · Gerace et al. · 2006 [cited by applicant]
US 20070082347A1 · Lanchbury et al. · 2007 [cited by applicant]
US 20070087323A1 · Armitage et al. · 2007 [cited by applicant]
US 20070099209A1 · Clarke et al. · 2007 [cited by applicant]
US 20070243537A1 · Tuck et al. · 2007 [cited by applicant]
US 20070281314A1 · Benson · 2007 [cited by applicant]
US 20080009779A1 · Fabo · 2008 [cited by examiner]
US 20080032293A1 · Szabo et al. · 2008 [cited by applicant]
US 20080131902A1 · Maor et al. · 2008 [cited by applicant]
US 20080138819A1 · Vogt · 2008 [cited by applicant]
US 20080200870A1 · Palmroos et al. · 2008 [cited by applicant]
US 20080274908A1 · Chang · 2008 [cited by applicant]
US 20090010997A1 · Haley · 2009 [cited by examiner]
US 20090082265A1 · Bartel et al. · 2009 [cited by applicant]
US 20090246768A1 · Sawalha et al. · 2009 [cited by applicant]
US 20090263792A1 · Miyata et al. · 2009 [cited by applicant]
US 20090298060A1 · Lal et al. · 2009 [cited by applicant]
US 20090299640A1 · Ellis et al. · 2009 [cited by applicant]
US 20100086501A1 · Chang et al. · 2010 [cited by applicant]
US 20100105102A1 · Hanes et al. · 2010 [cited by applicant]
US 20100239648A1 · Smith · 2010 [cited by examiner]
US 20100267033A1 · Abbas et al. · 2010 [cited by applicant]
US 20100279877A1 · Vogt · 2010 [cited by applicant]
US 20110059113A1 · Celebi · 2011 [cited by applicant]
US 20110158953A1 · Scott · 2011 [cited by applicant]
US 20110159496A1 · Kashani-Sabet et al. · 2011 [cited by applicant]
US 20110160080A1 · Chang · 2011 [cited by applicant]
US 20110262464A1 · Chin et al. · 2011 [cited by applicant]
US 20110287034A1 · Frank et al. · 2011 [cited by applicant]
US 20120065086A1 · Benson · 2012 [cited by applicant]
US 20120071343A1 · Ma et al. · 2012 [cited by applicant]
US 20120201750A1 · Ryu · 2012 [cited by applicant]
US 20130060184A1 · Rea · 2013 [cited by examiner]
US 20130079423A1 · Abkevich et al. · 2013 [cited by applicant]
US 20130143747A1 · Gutin et al. · 2013 [cited by applicant]
US 20130244256A1 · Clarke et al. · 2013 [cited by applicant]
US 20130296185A1 · Benson · 2013 [cited by applicant]
US 20130302242A1 · Stone et al. · 2013 [cited by applicant]
US 20130344481A1 · Kashani et al. · 2013 [cited by applicant]
US 20140045915A1 · Skog et al. · 2014 [cited by applicant]
US 20140154684A1 · Chang · 2014 [cited by applicant]
US 20140206574A1 · Chapman et al. · 2014 [cited by applicant]
US 20140323331A1 · Chang et al. · 2014 [cited by applicant]
US 20150005184A1 · Alsobrook et al. · 2015 [cited by applicant]
US 20150259739A1 · Chang et al. · 2015 [cited by applicant]
US 20150361500A1 · Ang et al. · 2015 [cited by applicant]
US 20160024595A1 · Alsobrook, II · 2016 [cited by applicant]
US 20180110500A1 · Palmer · 2018 [cited by examiner]
US 20190290799A1 · Arshi · 2019 [cited by examiner]
US 20190367994A1 · Chang · 2019 [cited by applicant]
US 20190369119A1 · Zhuang et al. · 2019 [cited by applicant]
US 20200149115A1 · Dobak et al. · 2020 [cited by applicant]
US 20200289099A1 · Palmer et al. · 2020 [cited by applicant]
US 20200308649A1 · Dobak et al. · 2020 [cited by applicant]
US 20200308657A1 · Dobak et al. · 2020 [cited by applicant]
US 20200319205A1 · Dobak et al. · 2020 [cited by applicant]
US 20200383665A1 · Palmer et al. · 2020 [cited by applicant]
US 20200383835A1 · Barr · 2020 [cited by examiner]
US 20200407800A1 · Dobak et al. · 2020 [cited by applicant]
US 20210196247A1 · Palmer et al. · 2021 [cited by applicant]
US 20210198749A1 · Chang · 2021 [cited by applicant]
US 20210212994A1 · Lebo · 2021 [cited by examiner]
US 20210222246A1 · Dobak et al. · 2021 [cited by applicant]
US 20210222247A1 · Dobak et al. · 2021 [cited by applicant]
US 20210222258A1 · Chang · 2021 [cited by applicant]
US 20210246514A1 · Chang · 2021 [cited by applicant]
US 20210324480A1 · Dobak et al. · 2021 [cited by applicant]
US 20210330245A1 · Dobak, III et al. · 2021 [cited by applicant]
US 20210332442A1 · Dobak, III et al. · 2021 [cited by applicant]
US 20210345995A1 · Dobak, III et al. · 2021 [cited by applicant]
US 20210393542A1 · McTavish · 2021 [cited by examiner]
US 20220162682A1 · Dobak et al. · 2022 [cited by applicant]
US 20220387005A1 · Dobak, III et al. · 2022 [cited by applicant]
US 20230142201A1 · Dobak et al. · 2023 [cited by applicant]
US 20230157638A1 · David · 2023 [cited by examiner]
US 20240075182A1 · Cahill · 2024 [cited by examiner]
US 20240350086A1 · David · 2024 [cited by examiner]
US 20240358985A1 · Schell · 2024 [cited by examiner]
AU 2005233547A1 · 2005 [cited by applicant]
JP 2001161697A · 2001 [cited by applicant]
WO WO0010579A1 · 2000 [cited by applicant]
WO WO03001985A2 · 2003 [cited by applicant]
WO WO2005100603A2 · 2005 [cited by applicant]
WO WO2006002433A2 · 2006 [cited by applicant]
WO WO2006039399A2 · 2006 [cited by applicant]
WO WO2007124072A2 · 2007 [cited by applicant]
WO WO2008137772A1 · 2008 [cited by applicant]
WO WO2009140550A2 · 2009 [cited by applicant]
WO WO2010025341A2 · 2010 [cited by applicant]
WO WO2010097773A1 · 2010 [cited by applicant]
WO WO2011039734A2 · 2011 [cited by applicant]
WO WO2012013931A1 · 2012 [cited by applicant]
WO WO2012115885A1 · 2012 [cited by applicant]
WO WO2012125411A1 · 2012 [cited by applicant]
WO WO2012174282A2 · 2012 [cited by applicant]
WO WO2013022995A2 · 2013 [cited by applicant]
WO WO2013033609A2 · 2013 [cited by applicant]
WO WO2013098797A2 · 2013 [cited by applicant]
WO WO2013184905A1 · 2013 [cited by applicant]
WO WO2014028461A2 · 2014 [cited by applicant]
WO WO2014028884A2 · 2014 [cited by applicant]
WO WO2014176446A1 · 2014 [cited by applicant]
WO WO2014210467A1 · 2014 [cited by applicant]
WO WO2016014705A1 · 2016 [cited by applicant]
WO WO2016179043A1 · 2016 [cited by applicant]
WO WO2017165199A1 · 2017 [cited by applicant]
WO WO2018191268A1 · 2018 [cited by applicant]
WO WO2019161126A1 · 2019 [cited by applicant]
WO WO2019183620A1 · 2019 [cited by applicant]
WO WO2019217478A1 · 2019 [cited by applicant]
WO WO2020008192A2 · 2020 [cited by applicant]
WO WO2020035707A1 · 2020 [cited by applicant]
WO WO2020198229A1 · 2020 [cited by applicant]
WO WO2020206085A1 · 2020 [cited by applicant]
Dermtech sticker collects skin cells so doctors can test for cancer | Fox 10 Azam, YouTube May 21, 2021, viewed online Nov. 18, 2024 at URL: https://www.youtube.com/watch?v=Gch0Vg95Xn0. [cited by examiner]
Albert et al. Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. J Am Acad Dermatol 23(2 Pt 1):308-310 (1990). [cited by applicant]
Bolshakov et al. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res. 9(1):228-34 (Jan. 2003). [cited by applicant]
Hayre. Oxytocin Levels Inversely Correlate With Skin Age Score and Solar Damage. J Drugs Dermatol 19(12):1146-1148 (2020). [cited by applicant]
U.S. Appl. No. 14/199,900 Notice of Allowance dated Mar. 30, 2015. [cited by applicant]
U.S. Appl. No. 16/522,291 Office Action dated Dec. 7, 2021. [cited by applicant]
U.S. Appl. No. 16/522,291 Office Action dated Sep. 16, 2021. [cited by applicant]
U.S. Appl. No. 17/002,676 Office Action dated Mar. 13, 2024. [cited by applicant]
U.S. Appl. No. 17/195,541 Office Action dated Sep. 28, 2022. [cited by applicant]
U.S. Appl. No. 17/217,568 Office Action dated Feb. 14, 2023. [cited by applicant]
U.S. Appl. No. 17/217,568 Office Action dated Feb. 15, 2024. [cited by applicant]
U.S. Appl. No. 17/217,568 Office Action dated Sep. 28, 2023. [cited by applicant]
U.S. Appl. No. 17/217,573 Office Action dated Feb. 1, 2023. [cited by applicant]
U.S. Appl. No. 17/217,573 Office Action dated Sep. 6, 2023. [cited by applicant]
U.S. Appl. No. 16/886,611 Office Action dated Mar. 25, 2024. [cited by applicant]
Armstrong et al., The epidemiology of UV induced skin cancer. Journal of Photochemistry and Photobiology B: Biology 63(1-3):8-18 (2001). [cited by applicant]
Baehrecke. miRNAs: micro managers of programmed cell death. Curr Biol 13(12):R473-R475 (2003). [cited by applicant]
Baldi et al. cDNA array technology in melanoma: an overview. J. Cell. Physiol. 196(2):219-223 (2003). [cited by applicant]
Bartel. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2): 281-297 (2004). [cited by applicant]
Becker et al. Mouse models for melanoma: a personal perspective. Experimental Dermatology 19:157-164 (2010). [cited by applicant]
Benson et al. An analysis of select pathogenic messages in lesional and non-lesional psoriatic skin using non-invasive tape harvesting. Journal of Investigative Dermatology 126:2234-2241 (2006). [cited by applicant]
Berardesca et al., Reduced ultraviolet-induced DNA damage and apoptosis in human skin with topical application of a photolyase-containing DNA repair enzyme cream: clues to skin cancer prevention. Molecular Medicine Repo… [cited by applicant]
Booken et al. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3. Leukemia 22(2):393-9 (2008). [cited by applicant]
Borevitz et al. Large-scale identification of single-feature polymorphisms in complex genomes. Genome Res 13(3):513-523 (2003). [cited by applicant]
Brand et al. Untersuchung menschlicher Hautlymphe: Unterscheiden sich irritative and allergische Kontaktdermatitiden benglich ihres Zytokinmusters? Zeitschrift for Hautkrankheiten, 72:435-440 (1997). (English Abstract). [cited by applicant]
Brehmer-Andersson et al. Tape-Stripping Method for Cytological Diagnosis of Mycosis Fungoides. Acta Derm-Venereol 47:177-180 (1967). [cited by applicant]
Brennecke et al. Bantam encodes a developmentally regulate microRNA that control cell proliferation and regulates the proapoptotic gene hid in [cited by applicant]
Breslow. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg. 172:902-908 (1970). [cited by applicant]
Carr et al. Gene-expression profiling in human cutaneous melanoma. Oncogene 22(20):3076-3080 (2003). [cited by applicant]
Cerda et al. Geometry and Physics of Wrinkling. Phys Rev Lett 90(7):074302 (2003). [cited by applicant]
Chen et al. MicroRNAs modulate hematopoietic lineage differentiation. Science 303(5654):83-86 (2004). [cited by applicant]
Childs. Noninvasive gene expression testing in amelanotic melanoma. JAMA Dermatol 154(2):223-224 (2018). [cited by applicant]
Choi et al. Genomic landscape of cutaneous T cell lymphoma. Nat Genet. 47(9):1011-9 (2015). [cited by applicant]
Chuaqui et al. Post-analysis follow-up and validation of microarray experiments. Nature Genetics 32(Supp):509-514 (2002). [cited by applicant]
Ciafre et al. Extensive modulation of a set of MicroRNAs in primary glioblastoma. Biochem Biophys Res Commun. 334(4):1351-1358 (2005). [cited by applicant]
Co-pending U.S. Appl. No. 29/770,783, inventors Dobak; John et al., filed on Feb. 16, 2021. [cited by applicant]
Co-pending U.S. Appl. No. 29/770,784, inventors Dobak; John et al., filed on Feb. 16, 2021. [cited by applicant]
Co-pending U.S. Appl. No. 29/770,785, inventors Dobak; John et al., filed on Feb. 16, 2021. [cited by applicant]
Co-pending U.S. Appl. No. 29/770,786, inventors Dobak; John et al., filed on Feb. 16, 2021. [cited by applicant]
Cummins et al. The colorectal microRNAome. PNAS USA 103(10):3687-3692 (2006). [cited by applicant]
Dalbe et al. Multiscale Stick-Slip Dynamics of Adhesive Tape Peeling. Phys Rev Lett 115(12):128301 (2015). [cited by applicant]
De Zotti et al. Bending to Kinetic Energy Transfer in Adhesive Peel Front Microinstability. Phys Rev Lett 122(6):068005 (2019). [cited by applicant]
Deboyes et al., Reduced number of actinic keratoses with topical application of DNA repair enzyme creams. Journal of drugs in dermatology: JDD 9(12):1519-1521 (2010). [cited by applicant]
Dembinska-Kiec et al. Proangiogenic activity of beta-carotene is coupled with the activation of endothelial cell chemotaxis. Biochimica et Biophysica Acta1740:222-239 (2005). [cited by applicant]
Dulmage et al. Lessons learned from gene expression profiling of cutaneous T-cell lymphoma. Br J Dermatol 169(6):1188-97 (2013). [cited by applicant]
Edelman et al. Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profiles. Bioinformatics 22(14):e108-116 (2006). [cited by applicant]
Efron et al. Empirical hayes methods and false discovery rates for microarrays. Genet Epidemiol 23(1):70-86 (2002). [cited by applicant]
Elwood et al., Melanoma and sun exposure: an overview of published studies. International Journal of Cancer 73(2):198-203 (1997). [cited by applicant]
Esquela-Kerscher et al., Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6(4):259-69 (2006). [cited by applicant]
Ferris et al. Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month follow-up of negative test results and utility data from a large US registry study. Dermatology Online J 25(5)… [cited by applicant]
Ferris et al. Noninvasive analysis of high-risk driver mutations and gene expression profiles in primary cutaneous melanoma. J Invest Dermatol 139:1127-1134 (2019). [cited by applicant]
Ferris et al. Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions. Melanoma Res 28(5):478-482 (2018). [cited by applicant]
Ferris et al. Utility of a noninvasive 2-gene molecular assay for cutaneous melanoma and effect on the decision to biopsy. JAMA Dermatol 153(7):675-680 (2017). [cited by applicant]
Garcia-Sancha et al. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma (Review). Int. J. Mol. Sci. 20:2181 (2019). [cited by applicant]
Garofano et al. Comparison of Powerplex® 16 System and Other Multiplex STR Typing Kits on Casework, (Reporto Carabinieri Investigazioni Scientifiche, Parma, Italia.), 2000. Reference available at: http://www. promeea.co… [cited by applicant]
Garrett et al Tired of the same old grind in the new genomics and proteomics era? Targets Innovations in Genomics & Proteomics 1(5):156-162 (2002). [cited by applicant]
Genecard (www.genecards.org)—Accessed Nov. 11, 2009. [cited by applicant]
Gerami et al. Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma. J Am Acad Dermatol 76(1):114-120.e2 (2017). [cited by applicant]
Gershenwald et al. Gene expression profiling of human cutaneous melanoma: are we there yet? Cancer Biol Ther 3(1):121-123 (2004). [cited by applicant]
Gibson et al. A Novel Method for Real Time Quantitative RT-PCR. Genome Research 6:995-1001 (1996). [cited by applicant]
Gloster et al. The epidemiology of skin cancer. Dermatol Surg. 22(3):217-226 (1996). [cited by applicant]
Gong et al. MiRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN. Cell Mol Biol Lett. 24:9 (2019). [cited by applicant]
Graengsjoe et al. Different Pathways in Irritant Contact Eczema? Early Differences in the Epidermal Elemental Content and Expression of Cytokines After Application of 2 Different Irritants. Contact Dermatitis 35(6):355-… [cited by applicant]
Hammond MicroRNAs as oncogenes. Curr Opin Genet Dev 16(1):4-9 (2006). [cited by applicant]
Haqq et al. The gene expression signatures of melanoma progression. PNAS USA 102(17):6092-6097 (2005). [cited by applicant]
Hirao et al. Elevation of Interleukin 1 Receptor Antagonist in the Stratum Corneum of Sun-Exposed and Ultraviolet B-Irradiated Human Skin. The Journal of Investigative Dermatology 106(5):767-768 (1972). [cited by applicant]
Holleran et al. Regulation of epidermal sphingolipid synthesis by permeability barrier function. J. Lipid Research 32:1151-1158 (1991). [cited by applicant]
Hornberger et al. Clinical and economic implications of a noninvasive molecular pathology assay for early detection of melanoma. JAMA Dermatol 154(9):1-8 (2018). [cited by applicant]
Howie et al. Epidermal keratinocyte production of interferon-gamma immunoreactive protein and mRNA is an early event in allergic contact dermatitis. Journal of Investigative Dermatology 106(6):1218-1223 (1996). [cited by applicant]
Hu et al. MicroRNA-186 promotes cell proliferation and inhibits cell apoptosis in cutaneous squamous cell carcinoma by targeting RETREG1. Expt. Therapeutic Medicine 17:1930-1938 (2019). [cited by applicant]
Instructions for use DermTech adhesive skin biopsy kit. DermTech. Available at http://dermtech.com/wp-content/uploads/2015/10/dermtech-ifu-skin-collection-v7.pdf (Revised data Oct. 2015) (1 pg.). [cited by applicant]
Iorio et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16):7065-7070 (2005). [cited by applicant]
Itoh et al. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS One 8(10):e77673 (2013). [cited by applicant]
Jansen et al. Gene expression analysis differentiates melanomas from Spitz nevi. J Drugs Dermatol 17(5):574-576 (2018). [cited by applicant]
Jemal et al. Cancer statistics. CA Cancer J Clin 2003. 53(1):5-26 (2003). [cited by applicant]
Jovanovic. Molecular studies of melanoma. Archive of Oncology13:75-77 (2005). [cited by applicant]
Kalia et al. Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo. Biophys J 71(5):2692-2700 (1996). [cited by applicant]
Katz et al. Skin surface touch print for diagnosing fungal infections. American Family Physician 31(4):189-194 (1985). [cited by applicant]
Keppler, D. Towards novel anti-cancer strategies based on cystatin function. Cancer Letters 235(2):159-176 (2006). [cited by applicant]
Kim et al. The promise of microarray technology in melanoma care. Cancer Contro. 9(1):49-53 (2002). [cited by applicant]
Koga et al. Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res. 19:1462-1470 (2009). [cited by applicant]
Kohnken et al. MicroRNAs in Cutaneous T-Cell Lymphoma: The Future of Therapy. J Invest Dermatol. 139(3):528-534 (2019). [cited by applicant]
Kong et al. A multivariate approach for integrating genome-wide expression data and biological knowledge. Bioinformatics 22(19):2373-2380 (2006). [cited by applicant]
Koning et al. T Cell Subsets and Cytokines in Allergic and Non-allergic Children. I. Analysis of IL-4 IFN-gamma and IL-13 mRNA Expression and Protein Production. Cytokine 9(6):416-426 (1997). [cited by applicant]
Kricker et al., Sun exposure and non-melanocytic skin cancer. Cancer Causes & Control 5(4):367-392 (1994). [cited by applicant]
Lee et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854 (1993). [cited by applicant]
Lindahl et al., Quality control by DNA repair. Science 286(5446):1897-1905 (1999). [cited by applicant]
Litvinov et al. Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators. Oncoimmunology 6(5):e1306618 (2017). [cited by applicant]
Litvinov et al., The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-Cell Lymphoma (CTCL). Clin Cancer Res. 21(12):2820-2829 (2015). [cited by applicant]
Liu et al. Inhibition of p38 MAPK signaling augments skin tumorigenesis via NOX2 driven ROS generation. PLoS One 9(5):e97245 (2014). [cited by applicant]
Lucentini, J. Gene Association Studies Typically Wrong. The Scientist, 18(24):20 (2004). [cited by applicant]
Maddox et al. Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein.J. Exp. Med. 158:1211-1226 (1983). [cited by applicant]
Marin et al., Molluscan shell proteins: primary structure, origin, and evolution. Current Topics in Developmental Biology 80:209-276 (2007). [cited by applicant]
Marttin et al. A Critical Comparison of Methods to Quantify Stratum corneum removed by Tape Stripping. Skin Pharmacology 9:69-77 (1996). [cited by applicant]
McCarty et al. Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis. Melanoma Res 13(4):379-387 (2003). [cited by applicant]
Méhul et al. Proteomic analysis of stratum corneum in Cutaneous T-Cell Lymphomas and psoriasis. Exp Dermatol 28(3):317-321 (2019). [cited by applicant]
Michael et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 1(12):882-891 (2003). [cited by applicant]
Mitchell et al. Global analysis of cellular transcription following infection with an HIV-based vector. Mol Ther 8(4):674-687 (2003). [cited by applicant]
Morhenn et al. A noninvasive method for quantifying and distinguishing inflammatory skin reactions. Journal of the American Academy of Dermatology 41(5 Pt 1):687-692(1999). [cited by applicant]
Nair et al. Virus-encoded microRNAs: novel regulators of gene expression. Trends Microbiol. 14(4):169-175 (2006). [cited by applicant]
Neagu et al. miRNAs in the Diagnosis and Prognosis of Skin Cancer. Front Cell Dev Biol 8:71 (2020 ). [cited by applicant]
Orro et al., Development of TAP, a non-invasive test for qualitative and quantitative measurements of biomarkers from the skin surface. Biomarker Research 2: (2014). [cited by applicant]
Page et al. The Power Atlas: a power and sample size atlas for microarray experimental design and research. BMC Bioinformatics 7:84 (2006). [cited by applicant]
Paik et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Eng J Med 351(27):2817-2826 (2004). [cited by applicant]
Pang et al. Pathway analysis using random forests classification and regression. Bioinformatic 22(16):2028-2036 (2006). [cited by applicant]
Pavey et al. Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene 23(23):4060-4067 (2004). [cited by applicant]
PCT/US2009/44035 International Search Report and Written Opinion dated Sep. 3, 2009. [cited by applicant]
PCT/US2016/30287 International Search Report and Written Opinion dated Aug. 16, 2016. [cited by applicant]
Perkins et al. Development of a Noninvasive Method for Assessing Human Skin Irritation. The Toxicologist 36(1):365 (1997). [cited by applicant]
Petit-Zeman. MicroRNAs hit the big time. Nat Rev Drug Discov. 5(1):5 (2006). [cited by applicant]
Preston et al., Nonmelanoma cancers of the skin. New England Journal of Medicine 327(23):1649-1662 (1992). [cited by applicant]
Reinhart et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403(6772):901-906 (2000). [cited by applicant]
Rivers et al. Non-invasive gene expression testing to rule out melanoma. Skin Therapy Letter 23(5):1-4 (2018). [cited by applicant]
Rivers et al. Ruling out Melanoma: A practical guide to improving performance through non-invasive gene expression testing. Skin Therapy Letter: Family Practice Edition 14(1):4-6 (2019). [cited by applicant]
Rosenthal et al., Ultraviolet B light induces rapid changes in gene expression as detected by non-invasive, adhesive skin biopsies. [Poster Presentation, Orlando Florida] (Jun. 2019). [cited by applicant]
Seftor et al. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Can… [cited by applicant]
Shen et al., Epigenetic and genetic dissections of UV-induced global gene dysregulation in skin cells through multi-omics analyses. Scientific Reports 7:42646 (2017). [cited by applicant]
Shen et al., Transcriptome analysis identifies the dysregulation of ultraviolet target genes in human skin cancers. PLoS One 11(9):e0163054 [1-14] (2016). [cited by applicant]
Shin et al. Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome. Blood 110(8):3015-3027 (2007). [cited by applicant]
Siegel et al. Further consideration of the pigmented lesion assay-reply. JAMA Dermatol 155(3):393-394 (2019). [cited by applicant]
Slack et al. MicroRNAs as a potential magic bullet in cancer. Future Oncol. 2(1):73-82 (2006). [cited by applicant]
Slas. From Laboratory to Clinic: Novel Skin Sampling Technique Simplifies Disease Detection. Available at https://www.slas.org/eln/from-laboratory-to-clinic-novel-skin-sampling-technique-simplifies-disease-detection/ (2… [cited by applicant]
Smyth et al. Statistical issues in eDNA microarray data analysis. Methods Mol Biol 224:111-136 (2003). [cited by applicant]
Stege et al., Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proceedings of the National Academy of Sciences 97(4):1790-1795 (2000). [cited by applicant]
Steinert et al., Small proline-rich proteins are cross-bridging proteins in the cornified cell envelopes of stratified squamous epithelia. Journal of Structural Biology 122(1-2):76-85 (1998). [cited by applicant]
Stoddard et al., Improvement of actinic keratoses using topical DNA repair enzymes: a randomized placebo-controlled trial. Journal of Drugs in Dermatology: JDD 16(10):1030-1034 (2017). [cited by applicant]
Stolz et al. Semiquantitative analysis of histologic criteria in thin malignant melanomas. J Am Acad Dermato. 20(6):1115-1120 (1989). [cited by applicant]
Stuart et al. In silico dissection of cell-type—associated patterns of gene expression in prostate cancer. PNAS USA 101(2):615-620 (2004). [cited by applicant]
Su et al. Identification of tumor-suppressor genes using human melanoma cell lines UACC903, UACC903(+6), and SRS3 by comparison of expression profiles. Mol Carcinog 28(2):119-127 (2000). [cited by applicant]
Tagawa. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia. 19(11):2013-2016 (2005). [cited by applicant]
Takashi et al. Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip Are immunogenic in multiple melanoma patients. International Journal of Cancer 114(2):283-290 (2005). [cited by applicant]
Thoma. Light and dark in chromatin repair: repair of UV-induced DNA lesions by photolyase and nucleotide excision repair. The EMBO Journal 18(23):6585-6598 (1999). [cited by applicant]
Thoroddsen et al. Stick-slip substructure in rapid tape peeling. Phys Rev Lett 82(4 Pt 2):046107 (2010). [cited by applicant]
Tibshirani et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression. PNAS USA 99(10):6567-6572 (2002). [cited by applicant]
Torabian et al. Biomarkers for melanoma. Current Opinion in Oncology 17:167-171 (2005). [cited by applicant]
Torres et al. MicroRNA Ratios Distinguish Melanomas from Nevi. J Invest Dermatol . 140(1):164-173.e7 (2020). [cited by applicant]
U.S. Appl. No. 12/991,685 Office Action dated Mar. 13, 2013. [cited by applicant]
U.S. Appl. No. 12/991,685 Office Action dated Nov. 4, 2013. [cited by applicant]
U.S. Appl. No. 14/172,784 Office Action dated Apr. 23, 2015. [cited by applicant]
U.S. Appl. No. 14/199,900 Office Action dated Dec. 10, 2014. [cited by applicant]
U.S. Appl. No. 14/199,900 Pending Claims. [cited by applicant]
U.S. Appl. No. 14/832,966 Office Action dated Apr. 12, 2018. [cited by applicant]
U.S. Appl. No. 14/832,966 Office Action dated Aug. 10, 2017. [cited by applicant]
U.S. Appl. No. 14/832,966 Office Action dated Nov. 16, 2018. [cited by applicant]
U.S. Appl. No. 16/522,291 Office Action dated Apr. 28, 2021. [cited by applicant]
U.S. Appl. No. 16/522,291 Office Action dated Jan. 7, 2021. [cited by applicant]
Vaqué et al. PLCG1 mutations in cutaneous T-cell lymphomas. Blood 123(13):2034-43 (2014). [cited by applicant]
Volinia et al. A microRNA expression signature of human solid tumors defines cancer gene targets. PNAS USA 103(7):2257-2261 (2006). [cited by applicant]
Wachsman et al. Differentiation of melanoma from dysplastic nevi in suspicious pigmented skin lesions by non-invasive tape stripping. Journal of Dermatology 127(Supp 1s):S145 (2007). [cited by applicant]
Wachsman et al. Non-invasive genomic detection of melanoma, British Journal of Dermatology 164:797-806 (2011). [cited by applicant]
Wang et al. Why minimally invasive skin sampling techniques? A bright scientific future. Cutan Ocul Toxicol 30(1):1-6 (2011). [cited by applicant]
Washington Report: Skin Tape Stripping Method for Generic Dermatologic Drug Approval Remains in Question, http://www.aadassociation.org/old/washReports/dec99_washrep.html (1999). [cited by applicant]
Weigand et al. Removal of Stratum Corneum in Vivo: An Improvement of the Cellophane Tape Strapping Technique. The Journal of Investigative Dermatology 60(2):84-87 (1973). [cited by applicant]
Wolf et al., Topical treatment with liposomes containing T4 endonuclease V protects human skin in vivo from ultraviolet-induced upregulation of interleukin-10 and tumor necrosis factor-α. Journal of Investigative Dermat… [cited by applicant]
Wolyn et al. Light-response quantitative trait loci identified with composite interval and extreme array mapping in [cited by applicant]
Wong et al. Analysis of RNA recovery and gene expression in the epidermis using non-invasive tape stripping. J Dermatol Science 44:81-92 (2006). [cited by applicant]
Wong et al. Use of RT-PCR and DNA Microarrays to Characterize RNA Recovered by Non-Invasive Tape Harvesting of Normal and Inflamed Skin. Journal of Investigative Dermatology 123(1):159-167 (2004). [cited by applicant]
Wu et al. Preprocessing of oligonucleotide array data. Nat Biotechnol 22(6):656-658; author reply 658 (2004). [cited by applicant]
Wu et al. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J Comput Bio. 12(6):882-893 (2005). [cited by applicant]
Yanaihara et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 9(3):189-198 (2006). [cited by applicant]
Yao et al. An adhesive patch-based skin biopsy device for molecular diagnostics and skin microbiome studies. J Drugs Dermatol 16:979-986 (2017). [cited by applicant]
Yao et al. Analytical Characteristics of a Noninvasive Gene Expression Assay for Pigmented Skin Lesions. Assay Drug Del Technol 14(6):355-363 (2016). [cited by applicant]
Yarosh et al., Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice. Cancer Research 52(15):4227-4231 (1992). [cited by applicant]
Yarosh et al., Xeroderma pigmentosum study group. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. The Lancet 357(9260):926-929 (2001). [cited by applicant]
Zou et al., Strand opening by the UvrA2B complex allows dynamic recognition of DNA damage. The EMBO Journal 18(17):4889-4901 (1999). [cited by applicant]
Co-pending U.S. Appl. No. 29/866,396, inventor Gina Makris, filed Sep. 9, 2022. [cited by applicant]
Co-pending U.S. Appl. No. 29/866,397, inventor Gina Makris, filed Sep. 9, 2022. [cited by applicant]
Co-pending U.S. Appl. No. 29/866,398, inventor Gina Makris, filed Sep. 9, 2022. [cited by applicant]
Co-pending U.S. Appl. No. 29/866,399, inventor Gina Makris, filed Sep. 9, 2022. [cited by applicant]
Anderson et al.; “Variations in Physical Dimensions and Chemical Composition of Human Stratum Corneum”; The Journal of Investigative Dermatology; c. 1973; vol. 61; pp. 30-32. [cited by applicant]
Final Office Action issued Dec. 2, 2024 in corresponding U.S. Appl. No. 17/002,676. [cited by applicant]
Non-Final Office Action issued Feb. 24, 2025 in corresponding U.S. Appl. No. 17/183,589. [cited by applicant]
International Preliminary Report on Patentability issued in corresponding International Application No. PCT/US2016/030287 mailed Nov. 7, 2017. [cited by applicant]